 |
|
|
|
|
|
|
| Article 1 to 10 out of 108
|
|
-
Pulse Oximetry Entrenched as Standard-of-Care in Patient Monitoring, States Frost & Sullivan
(30 Jun 2009)
Pulse oximetry is often referred to as the fifth vital sign. The significance of continuous oxygenation monitoring in hospitals and other critical care settings cannot be doubted. Pulse oximetry technology has undergone considerable change over ......
-
Symyx Named Top 10 Life Science Software Vendor by IDC's Health Industry Insights
(29 Jun 2009)
Symyx Technologies, Inc. has announced it has been named one of the Top 10 Life Science Software Vendors in a May 2009 report published by Health Industry Insights, an IDC company. "The inclusion of specialty vendors in the enterprise life ......
-
Self-Monitoring and POC Diabetes Tests Reveal Potential for Significant Growth
(25 Jun 2009)
The European diabetes diagnostics market is poised for expansion with segments such as self-monitoring and point-of-care (POC) tests offering tremendous growth potential. Heightened efforts to generate awareness about diabetes and related ......
-
Frost & Sullivan: Demand for Energy-efficiency Offers High Potential for Electric Drives in the European Chemical Industry
(04 Jun 2009)
The increasing demand for energy-efficient systems coupled with the need for reliability in process applications offers significant potential for electric drives in the European chemical industry. Despite the economic slowdown and declining ......
-
CellaVision wins SwedenBio Award
(29 May 2009)
CellaVision AB is this year's winner of the SwedenBio Award for its exceptional contributions to the life-science industry during the year of 2008. Swedish Minister for Trade Ewa Björling handed the prize to CEO Yvonne Mårtensson at a ceremony ......
-
How will ‘Pharma 2.0’ fare vs Obama and credit crunch?
(27 Apr 2009)
In recent years, Pharma has begun to adapt its business model in response to growing industry constraints and the decline of primary-care focused blockbuster therapy. This process of change has recently been disrupted by unprecedented ......
-
BioInformatics Reports on Capitalizing on New Opportunities for Stem Cell Products
(09 Apr 2009)
BioInformatics, LLC announced the release of its newest report, Capitalizing on New Opportunities for Stem Cell Products. As a result of the March 9, 2009 reversal of the 2001 restrictions on federal funding of human embryonic stem cell ......
-
R&D Spending by U.S. Biopharmaceutical Companies Increases 3 Percent in 2008
(12 Mar 2009)
New statistics just released reveal that R&D investment in new medicines by the biopharmaceutical industry was $65.2 billion in 2008, an increase of 3 percent from 2007, according to a combined analysis conducted by Burrill & Company and the ......
-
AECOM Environment Collaborates with University of California at Santa Barbara on Sustainable Nanotechnology Initiative
(11 Mar 2009)
Initiative to study new environmental risks
AECOM Environment and the University of California at Santa Barbara (UCSB) are collaborating on the new Sustainable Nanotechnology Initiative (SNI) at UCSB’s Bren School of Environmental Science and Management. Nanotechnology involves ......
-
Carbon Nanotubes: Endless Opportunities
(23 Feb 2009)
Carbon nanotubes (CNTs) are the most popular and recognizable elements of present nanotechnology. Scientists and researchers now are discovering that carbon nanotubes could be more affordable and useful to many industrial areas, including flame ......
|
|
|
|
|
Top
analytica
analytica China
analytica Vietnam
analytica Anacon